tiprankstipranks
Sigma Healthcare Ltd (DE:S5YA)
FRANKFURT:S5YA
Germany Market

Sigma Healthcare Ltd (S5YA) Stock Forecast & Price Target

13 Followers
See the Price Targets and Ratings of:

S5YA Analyst Ratings

Strong Buy
10Ratings
Strong Buy
8 Buy
2 Hold
0 Sell
Based on 10 analysts giving stock ratings to
Sigma
Healthcare Ltd
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

S5YA Stock 12 Month Forecast

Average Price Target

€1.99
▲(20.00% Upside)
Based on 10 Wall Street analysts offering 12 month price targets for Sigma Healthcare Ltd in the last 3 months. The average price target is €1.99 with a high forecast of €2.17 and a low forecast of €1.57. The average price target represents a 20.00% change from the last price of €1.66.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"€0","3":"€3","0.75":"€0.75","1.5":"€1.5","2.25":"€2.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2.1690612,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€2.17</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.991921202,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€1.99</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.5665442,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€1.57</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,0.75,1.5,2.25,3],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.62,1.662235476923077,1.704470953846154,1.7467064307692308,1.7889419076923077,1.8311773846153847,1.8734128615384615,1.9156483384615384,1.9578838153846152,2.000119292307692,2.0423547692307693,2.084590246153846,2.126825723076923,{"y":2.1690612,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.62,1.6486093232307693,1.6772186464615386,1.7058279696923078,1.734437292923077,1.7630466161538463,1.7916559393846154,1.8202652626153846,1.8488745858461537,1.877483909076923,1.9060932323076922,1.9347025555384616,1.9633118787692307,{"y":1.991921202,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.62,1.6158880153846156,1.6117760307692308,1.6076640461538463,1.6035520615384615,1.599440076923077,1.5953280923076925,1.5912161076923077,1.5871041230769232,1.5829921384615386,1.5788801538461539,1.5747681692307693,1.5706561846153846,{"y":1.5665442,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.591,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.551,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.68,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.617,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.727,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.538,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.637,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.756,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.607,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.58,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.66,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.76,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.62,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€2.17Average Price Target€1.99Lowest Price Target€1.57
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi
€1.93
Hold
16.15%
Upside
Reiterated
06/15/26
Sigma Healthcare Ltd (S5YA) Receives a Hold from Citi
Morgan Stanley Analyst forecast on DE:S5YA
Morgan Stanley
Morgan Stanley
€1.93
Buy
16.15%
Upside
Reiterated
06/10/26
Morgan Stanley Sticks to Its Buy Rating for Sigma Healthcare Ltd (S5YA)
Macquarie Analyst forecast on DE:S5YA
Unknown Analyst
Macquarie
Not Ranked
Macquarie
€2.11
Buy
27.04%
Upside
Reiterated
06/09/26
Sigma Healthcare Ltd (S5YA) Gets a Buy from Macquarie
Ord Minnett Analyst forecast on DE:S5YA
Ord Minnett
Ord Minnett
€1.99€2.05
Buy
23.41%
Upside
Reiterated
05/06/26
Sigma Healthcare Ltd (S5YA) Receives a Buy from Ord Minnett
J.P. Morgan Analyst forecast on DE:S5YA
J.P. Morgan
J.P. Morgan
€2.11
Buy
27.04%
Upside
Reiterated
05/06/26
J.P. Morgan Reaffirms Their Buy Rating on Sigma Healthcare Ltd (S5YA)
Jefferies Analyst forecast on DE:S5YA
Jefferies
Jefferies
€1.84€1.99
Buy
19.78%
Upside
Reiterated
05/05/26
Sigma Healthcare Ltd (S5YA) Receives a Buy from Jefferies
UBS
€2.02€2.05
Buy
23.41%
Upside
Reiterated
05/05/26
UBS Keeps Their Buy Rating on Sigma Healthcare Ltd (S5YA)
RBC Capital
€1.51€1.57
Hold
-5.63%
Downside
Reiterated
05/04/26
RBC Capital Reaffirms Their Hold Rating on Sigma Healthcare Ltd (S5YA)
Jarden
€2.17
Buy
30.67%
Upside
Reiterated
05/04/26
Sigma Healthcare Ltd (S5YA) Gets a Buy from Jarden
Morgans
€2.02
Buy
21.96%
Upside
Upgraded
04/12/26
Positive Report for Sigma Healthcare Ltd (S5YA) from Morgans
Bell Potter Analyst forecast on DE:S5YA
Bell Potter
Bell Potter
€1.81
Hold
8.89%
Upside
Reiterated
02/27/26
Sigma Healthcare Ltd (S5YA) Receives a Hold from Bell Potter
Goldman Sachs Analyst forecast on DE:S5YA
Goldman Sachs
Goldman Sachs
€2.11
Buy
27.04%
Upside
Initiated
01/21/26
Sigma Healthcare: Undervalued Growth Leveraging Operating Scale, Private Label Expansion, and International Pharmacy Opportunities
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi
€1.93
Hold
16.15%
Upside
Reiterated
06/15/26
Sigma Healthcare Ltd (S5YA) Receives a Hold from Citi
Morgan Stanley Analyst forecast on DE:S5YA
Morgan Stanley
Morgan Stanley
€1.93
Buy
16.15%
Upside
Reiterated
06/10/26
Morgan Stanley Sticks to Its Buy Rating for Sigma Healthcare Ltd (S5YA)
Macquarie Analyst forecast on DE:S5YA
Unknown Analyst
Macquarie
Not Ranked
Macquarie
€2.11
Buy
27.04%
Upside
Reiterated
06/09/26
Sigma Healthcare Ltd (S5YA) Gets a Buy from Macquarie
Ord Minnett Analyst forecast on DE:S5YA
Ord Minnett
Ord Minnett
€1.99€2.05
Buy
23.41%
Upside
Reiterated
05/06/26
Sigma Healthcare Ltd (S5YA) Receives a Buy from Ord Minnett
J.P. Morgan Analyst forecast on DE:S5YA
J.P. Morgan
J.P. Morgan
€2.11
Buy
27.04%
Upside
Reiterated
05/06/26
J.P. Morgan Reaffirms Their Buy Rating on Sigma Healthcare Ltd (S5YA)
Jefferies Analyst forecast on DE:S5YA
Jefferies
Jefferies
€1.84€1.99
Buy
19.78%
Upside
Reiterated
05/05/26
Sigma Healthcare Ltd (S5YA) Receives a Buy from Jefferies
UBS
€2.02€2.05
Buy
23.41%
Upside
Reiterated
05/05/26
UBS Keeps Their Buy Rating on Sigma Healthcare Ltd (S5YA)
RBC Capital
€1.51€1.57
Hold
-5.63%
Downside
Reiterated
05/04/26
RBC Capital Reaffirms Their Hold Rating on Sigma Healthcare Ltd (S5YA)
Jarden
€2.17
Buy
30.67%
Upside
Reiterated
05/04/26
Sigma Healthcare Ltd (S5YA) Gets a Buy from Jarden
Morgans
€2.02
Buy
21.96%
Upside
Upgraded
04/12/26
Positive Report for Sigma Healthcare Ltd (S5YA) from Morgans
Bell Potter Analyst forecast on DE:S5YA
Bell Potter
Bell Potter
€1.81
Hold
8.89%
Upside
Reiterated
02/27/26
Sigma Healthcare Ltd (S5YA) Receives a Hold from Bell Potter
Goldman Sachs Analyst forecast on DE:S5YA
Goldman Sachs
Goldman Sachs
€2.11
Buy
27.04%
Upside
Initiated
01/21/26
Sigma Healthcare: Undervalued Growth Leveraging Operating Scale, Private Label Expansion, and International Pharmacy Opportunities
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sigma Healthcare Ltd

3 Months
Tom GodfreyOrd Minnett
Success Rate
5/7 ratings generated profit
71%
Average Return
+21.29%
Copying Tom Godfrey's trades and holding each position for 3 Months would result in 71.43% of your transactions generating a profit, with an average return of +21.29% per trade.
1 Year
David StantonJefferies
Success Rate
6/7 ratings generated profit
86%
Average Return
+5.11%
Copying David Stanton's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +5.11% per trade.
2 Years
David StantonJefferies
Success Rate
6/7 ratings generated profit
86%
Average Return
+5.11%
Copying David Stanton's trades and holding each position for 2 Years would result in 85.71% of your transactions generating a profit, with an average return of +5.11% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

S5YA Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
0
0
0
0
0
Buy
8
10
11
12
9
Hold
6
5
4
3
3
Sell
1
0
0
0
0
Strong Sell
0
0
0
0
0
total
15
15
15
15
12
In the current month, S5YA has received 9 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. S5YA average Analyst price target in the past 3 months is 1.99.
Each month's total comprises the sum of three months' worth of ratings.

S5YA Financial Forecast

S5YA Earnings Forecast

Next quarter’s earnings estimate for S5YA is €0.02 with a range of €0.02 to €0.02. The previous quarter’s EPS was €0.02. S5YA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year S5YA has Performed in-line its overall industry.
Next quarter’s earnings estimate for S5YA is €0.02 with a range of €0.02 to €0.02. The previous quarter’s EPS was €0.02. S5YA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year S5YA has Performed in-line its overall industry.

S5YA Sales Forecast

Next quarter’s sales forecast for S5YA is €3.17B with a range of €2.97B to €3.35B. The previous quarter’s sales results were €3.33B. S5YA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year S5YA has Performed in-line its overall industry.
Next quarter’s sales forecast for S5YA is €3.17B with a range of €2.97B to €3.35B. The previous quarter’s sales results were €3.33B. S5YA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year S5YA has Performed in-line its overall industry.

S5YA Stock Forecast FAQ

What is DE:S5YA’s average 12-month price target, according to analysts?
Based on analyst ratings, Sigma Healthcare Ltd’s 12-month average price target is 1.99.
    What is DE:S5YA’s upside potential, based on the analysts’ average price target?
    Sigma Healthcare Ltd has 20.00% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Sigma Healthcare Ltd a Buy, Sell or Hold?
          Sigma Healthcare Ltd has a consensus rating of Strong Buy, which is based on 8 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Sigma Healthcare Ltd’s share price target?
            The average share price target for Sigma Healthcare Ltd is 1.99. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €2.17 ,and the lowest forecast is €1.57. The average share price target represents 20.00% Increase from the current price of €1.66.
              What do analysts say about Sigma Healthcare Ltd?
              Sigma Healthcare Ltd’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.
                How can I buy shares of Sigma Healthcare Ltd?
                To buy shares of DE:S5YA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.